Portland, OR — Allied Market Research has published a comprehensive new report titled “Point of Care Lipid Test Market by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2031.” The global point of care lipid test market was valued at $284.9 million in 2021 and is projected to reach $426.6 million by 2031, growing at a CAGR of 4.1% from 2022 to 2031.
What Is Point of Care Lipid Testing?
Point of care testing (POCT) is a type of medical diagnostic testing that enables doctors and other healthcare professionals to obtain lab-quality diagnostic data quickly and accurately in real time. Point of care lipid tests are specifically used to calculate the blood’s triglyceride, lipoprotein, and cholesterol levels. Unlike conventional laboratory testing, these solutions deliver results within minutes — right at the patient’s bedside, clinic, or pharmacy — enabling faster clinical decisions and better patient outcomes.
Access Sample Data & Findings:
https://www.alliedmarketresearch.com/request-sample/A14046
High cholesterol often goes undetected, yet it can have serious health repercussions. When blood cholesterol levels are excessively high, plaque deposits form in the arteries, causing them to narrow and restricting blood flow to the heart — potentially triggering a heart attack. Point of care lipid testing plays a pivotal role in early detection and ongoing monitoring of such life-threatening conditions.
Key Market Drivers
Surge in obesity in the population, increase in government initiatives to promote healthy lifestyles, and increase in prevalence of cardiovascular disease and diabetes are the primary drivers of growth in the global point of care lipid test market.
The market trends driving growth include a rise in the geriatric population, an increase in the number of licensed medical centers, and a surge in self-awareness among populations regarding physical health. Moreover, sedentary lifestyles leading to the development of diseases such as heart disease, and increased awareness regarding routine testing and management of healthy lipid levels, are further expected to boost market growth during the forecast period.
The growth of the point of care lipid test market is also expected to be driven by high potential in untapped, emerging markets due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, and surge in demand for point of care lipid test instruments and consumables.
Market Segmentation Highlights
The report segments the global market by product type, application, and end user, uncovering several key trends:
- By Product Type: The consumables segment held the largest share in 2021, garnering nearly three-fourths of the global market, and is expected to maintain its dominance during the forecast period.
- By Application: The endogenous hyperlipidemia segment contributed to more than three-fourths of the global point of care lipid test market share in 2021 and is projected to remain dominant through 2031. This is attributed to the increase in prevalence of lipid disorders due to high-fat diets and sedentary lifestyles. The familial hypercholesterolemia segment, on the other hand, is expected to display the fastest CAGR of 5.2% throughout the forecast period.
- By End User: The diagnostic laboratories segment contributed to more than two-thirds of the global market share in 2021 and is projected to remain the leading end-user category through 2031. The diagnostic laboratories segment is projected to grow at a CAGR of 3.5% during the forecast period.
★ Request Pricing & Licensing Details @
https://www.alliedmarketresearch.com/purchase-enquiry/A14046
Regional Analysis
North America holds the highest market share and is expected to remain dominant during the forecast period. The dominance is attributed to the presence of a large patient population, strong presence of key players, well-developed healthcare infrastructure, and a higher number of research, development, and innovation activities.
Asia-Pacific is projected to register the highest CAGR of 5.4% during the forecast period. Increase in the geriatric population, rise in awareness regarding physical health, growth in healthcare expenditures, and surge in adoption of point of care lipid test products are the key driving factors in this region. Countries like China, India, and Brazil are emerging as significant contributors due to improving healthcare access and growing health-conscious consumer bases.
Innovation and Emerging Opportunities
Market leaders are focusing on developing strategies to increase the availability and use of lipid testing products in developing economies. Additionally, increasing appetite for technological advancements that improve speed, accuracy, and user-friendliness — as well as rising rates of adoption of self-testing wearable devices — are driving market growth.
Technological advancements such as multi-analyte analyzers, microfluidics integration, Bluetooth connectivity, and AI-driven risk scoring are further fueling market expansion. The rise of decentralized testing preferences and the global shift toward personalized medicine have bolstered the appeal of POC lipid diagnostics.
Competitive Landscape
Key players profiled in the global point of care lipid test market include Abbott Laboratories, Callegari, F. Hoffmann-La Roche Ltd., Menarini Group, Mico Bio Med, Nova Biomedical Corporation, SD Biosensor Inc., Sinocare Inc., VivaChek Biotech (Hangzhou) Co. Ltd., and Zoetis Inc. These companies have adopted strategies such as product development, market expansion, acquisitions, and strategic collaborations to strengthen their market presence.
Conclusion
The global point of care lipid test market is on a steady upward trajectory, driven by the dual forces of rising cardiovascular disease prevalence and the growing demand for fast, accessible diagnostics. As healthcare systems worldwide prioritize preventive care and early detection, point of care lipid testing is set to become an indispensable tool — not just in hospitals and clinics, but also in community health programs, pharmacies, and remote settings around the globe.
